Thermo Fisher Scientific
TMO
915 hedge funds and large institutions have $43.6B invested in Thermo Fisher Scientific in 2014 Q1 according to their latest regulatory filings, with 99 funds opening new positions, 319 increasing their positions, 374 reducing their positions, and 46 closing their positions.
166% more call options, than puts
Call options by funds: $472M | Put options by funds: $178M
115% more first-time investments, than exits
New positions opened: 99 | Existing positions closed: 46
9% more capital invested
Capital invested by funds: $40.1B → $43.6B (+$3.51B)
5% more funds holding
Funds holding: 872 → 915 (+43)
2% less funds holding in top 10
Funds holding in top 10: 84 → 82 (-2)
7.1% less ownership
Funds ownership: 99.65% → 92.55% (-7.1%)
15% less repeat investments, than reductions
Existing positions increased: 319 | Existing positions reduced: 374
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Temasek Holdings
Singapore
|
+$627M |
| 2 |
Capital Research Global Investors
Los Angeles,
California
|
+$377M |
| 3 |
Primecap Management
Pasadena,
California
|
+$367M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$261M |
| 5 |
CG
Carmignac Gestion
Paris,
France
|
+$182M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$748M |
| 2 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$544M |
| 3 |
SC
Sculptor Capital
New York
|
-$238M |
| 4 |
Barclays
London,
United Kingdom
|
-$154M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$146M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
ISL
951
Ingalls & Snyder LLC
New York
| – | -$222K | -2,000 | Closed |
|
|
HTC
952
Haverford Trust Company
Radnor,
Pennsylvania
| – | -$206K | -1,850 | Closed |
|
|
SEC
953
Seven Eight Capital
New York
| – | -$145K | -1,300 | Closed |
|
|
DSI
954
Daiwa SB Investments
Tokyo,
Japan
| – | -$130K | -1,170 | Closed |
|
|
MBE
955
Michael B. Elefante
| – | -$89K | -800 | Closed |
|
956
Group One Trading
Chicago,
Illinois
| – | -$86K | -775 | Closed |
|
|
MFBTD
957
MB Financial Bank - Trust Department
Rosemont,
Illinois
| – | -$45K | -400 | Closed |
|
|
S
958
SignatureFD
Atlanta,
Georgia
| – | -$42K | -379 | Closed |
|
|
ITIM
959
Indiana Trust & Investment Management
Mishawaka,
Indiana
| – | -$19K | -170 | Closed |
|
|
TIM
960
Tortoise Investment Management
White Plains,
New York
| – | -$15K | -139 | Closed |
|
|
BGIM
961
Brandywine Global Investment Management
Philadelphia,
Pennsylvania
| – | -$15K | -130 | Closed |
|
|
NC
962
NewSquare Capital
Newtown Square,
Pennsylvania
| – | -$7K | -62 | Closed |
|
963
Carson Wealth (CWM LLC)
Omaha,
Nebraska
| – | -$2K | -21 | Closed |
|
TMO Hedge Fund Activity: Q1 2014 in Review
915 of the 3,462 institutional investors tracked by Wall St. Rank reported a position in Thermo Fisher Scientific (TMO) for Q1 2014, worth a combined $43.6B — up 8.8% from $40.1B a quarter earlier.
Buyers outnumbered sellers: 99 funds opened new TMO positions and 46 closed out — a net gain of 53 holders — while 319 added to existing stakes and 374 trimmed.
The largest buyer was Temasek Holdings, opening a new position worth an estimated $627M. The largest seller was T. Rowe Price Associates, cutting an estimated $748M.
- 915 institutional investors held Thermo Fisher Scientific (TMO) as of Q1 2014, up from 872 in Q4 2013.
- Funds reported $43.6B of Thermo Fisher Scientific stock for Q1 2014, up 8.8% quarter-over-quarter.
- 99 funds opened new Thermo Fisher Scientific positions in Q1 2014 and 46 closed out, a net change of +53 holders.
- The largest Thermo Fisher Scientific buyer in Q1 2014 was Temasek Holdings, an estimated $627M added.
- The largest Thermo Fisher Scientific seller in Q1 2014 was T. Rowe Price Associates, an estimated $748M sold.
Based on aggregated 13F filings for Q1 2014.